Option Care Health (NASDAQ:OPCH) Issues FY 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCH - Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 1.550-1.590 for the period, compared to the consensus EPS estimate of 1.210. The company issued revenue guidance of $5.0 billion-$5.0 billion, compared to the consensus revenue estimate of $4.9 billion. Option Care Health also updated its FY 2025 guidance to 1.590-1.690 EPS.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OPCH. Jefferies Financial Group downgraded shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a report on Thursday, October 31st. The Goldman Sachs Group downgraded Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $29.71.

Option Care Health Stock Performance

NASDAQ OPCH traded up $3.73 during trading on Monday, reaching $27.72. The company's stock had a trading volume of 5,927,819 shares, compared to its average volume of 2,115,454. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The firm has a 50 day moving average price of $23.20 and a 200 day moving average price of $27.69. The firm has a market capitalization of $4.72 billion, a price-to-earnings ratio of 23.29, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.